Cargando…

A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma

The prognosis of colon adenocarcinoma (COAD) needs to be improved. Cuproptosis is a recently discovered cell death caused by intracellular overload of copper ions. There have been no reports about the cuproptosis-related prognostic model in COAD. First, we screened 30 differentially expressed genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Bixian, Lin, Jianwei, Ni, Anqi, Cai, Wei, Yu, Xinbo, Wang, Mingliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732569/
https://www.ncbi.nlm.nih.gov/pubmed/36505872
http://dx.doi.org/10.3389/fonc.2022.927028
_version_ 1784846165017100288
author Luo, Bixian
Lin, Jianwei
Ni, Anqi
Cai, Wei
Yu, Xinbo
Wang, Mingliang
author_facet Luo, Bixian
Lin, Jianwei
Ni, Anqi
Cai, Wei
Yu, Xinbo
Wang, Mingliang
author_sort Luo, Bixian
collection PubMed
description The prognosis of colon adenocarcinoma (COAD) needs to be improved. Cuproptosis is a recently discovered cell death caused by intracellular overload of copper ions. There have been no reports about the cuproptosis-related prognostic model in COAD. First, we screened 30 differentially expressed genes (DEGs) from patients with COAD using The Cancer Genome Atlas (TCGA) database. Gene Expression Omnibus (GEO) database was used as a validation set to establish a risk model of five cuproptosis-related genes (CKDN2A, SDHB, CCS, ULK1, and CMC1) by least absolute shrinkage and selection operator (LASSO) Cox regression analysis. In both TCGA and GEO cohorts, we could see that overall survival of COAD patients of the low-risk group was longer. Combined with the clinical characteristics, the risk score was found to be an independent prognostic factor. Furthermore, single-sample Gene Set Enrichment Analysis (ssGSEA) showed that the levels of Th1 and Treg immune cells changed both in TCGA and GEO databases. Finally, clinical samples were used to verify the mRNA and protein levels of five risk-model genes. In conclusion, this model could predict the prognosis of COAD patients, and the mechanism may be related to the changes in immune cells in the tumor microenvironment (TME).
format Online
Article
Text
id pubmed-9732569
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97325692022-12-10 A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma Luo, Bixian Lin, Jianwei Ni, Anqi Cai, Wei Yu, Xinbo Wang, Mingliang Front Oncol Oncology The prognosis of colon adenocarcinoma (COAD) needs to be improved. Cuproptosis is a recently discovered cell death caused by intracellular overload of copper ions. There have been no reports about the cuproptosis-related prognostic model in COAD. First, we screened 30 differentially expressed genes (DEGs) from patients with COAD using The Cancer Genome Atlas (TCGA) database. Gene Expression Omnibus (GEO) database was used as a validation set to establish a risk model of five cuproptosis-related genes (CKDN2A, SDHB, CCS, ULK1, and CMC1) by least absolute shrinkage and selection operator (LASSO) Cox regression analysis. In both TCGA and GEO cohorts, we could see that overall survival of COAD patients of the low-risk group was longer. Combined with the clinical characteristics, the risk score was found to be an independent prognostic factor. Furthermore, single-sample Gene Set Enrichment Analysis (ssGSEA) showed that the levels of Th1 and Treg immune cells changed both in TCGA and GEO databases. Finally, clinical samples were used to verify the mRNA and protein levels of five risk-model genes. In conclusion, this model could predict the prognosis of COAD patients, and the mechanism may be related to the changes in immune cells in the tumor microenvironment (TME). Frontiers Media S.A. 2022-11-25 /pmc/articles/PMC9732569/ /pubmed/36505872 http://dx.doi.org/10.3389/fonc.2022.927028 Text en Copyright © 2022 Luo, Lin, Ni, Cai, Yu and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Luo, Bixian
Lin, Jianwei
Ni, Anqi
Cai, Wei
Yu, Xinbo
Wang, Mingliang
A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
title A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
title_full A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
title_fullStr A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
title_full_unstemmed A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
title_short A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
title_sort novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732569/
https://www.ncbi.nlm.nih.gov/pubmed/36505872
http://dx.doi.org/10.3389/fonc.2022.927028
work_keys_str_mv AT luobixian anoveldefinedcuproptosisrelatedgenesignatureforpredictingtheprognosisofcolonadenocarcinoma
AT linjianwei anoveldefinedcuproptosisrelatedgenesignatureforpredictingtheprognosisofcolonadenocarcinoma
AT nianqi anoveldefinedcuproptosisrelatedgenesignatureforpredictingtheprognosisofcolonadenocarcinoma
AT caiwei anoveldefinedcuproptosisrelatedgenesignatureforpredictingtheprognosisofcolonadenocarcinoma
AT yuxinbo anoveldefinedcuproptosisrelatedgenesignatureforpredictingtheprognosisofcolonadenocarcinoma
AT wangmingliang anoveldefinedcuproptosisrelatedgenesignatureforpredictingtheprognosisofcolonadenocarcinoma
AT luobixian noveldefinedcuproptosisrelatedgenesignatureforpredictingtheprognosisofcolonadenocarcinoma
AT linjianwei noveldefinedcuproptosisrelatedgenesignatureforpredictingtheprognosisofcolonadenocarcinoma
AT nianqi noveldefinedcuproptosisrelatedgenesignatureforpredictingtheprognosisofcolonadenocarcinoma
AT caiwei noveldefinedcuproptosisrelatedgenesignatureforpredictingtheprognosisofcolonadenocarcinoma
AT yuxinbo noveldefinedcuproptosisrelatedgenesignatureforpredictingtheprognosisofcolonadenocarcinoma
AT wangmingliang noveldefinedcuproptosisrelatedgenesignatureforpredictingtheprognosisofcolonadenocarcinoma